000 01766 a2200577 4500
005 20250516195237.0
264 0 _c20151112
008 201511s 0 0 eng d
022 _a2041-1723
024 7 _a10.1038/ncomms4296
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aTanaka, Eriko
245 0 0 _aNotch2 activation ameliorates nephrosis.
_h[electronic resource]
260 _bNature communications
_c2014
300 _a3296 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650 0 4 _aAnimals
650 0 4 _aAntibodies, Monoclonal
_xpharmacology
650 0 4 _aApoptosis
_xdrug effects
650 0 4 _aCHO Cells
650 0 4 _aCricetinae
650 0 4 _aCricetulus
650 0 4 _aDoxorubicin
650 0 4 _aDrug Evaluation, Preclinical
650 0 4 _aFemale
650 0 4 _aHumans
650 0 4 _aKidney Diseases
_xchemically induced
650 0 4 _aMice, Inbred BALB C
650 0 4 _aMice, Inbred ICR
650 0 4 _aMice, Nude
650 0 4 _aPodocytes
_xdrug effects
650 0 4 _aProto-Oncogene Proteins c-akt
_xmetabolism
650 0 4 _aReceptor, Notch2
_xagonists
700 1 _aAsanuma, Katsuhiko
700 1 _aKim, Eunhee
700 1 _aSasaki, Yu
700 1 _aOliva Trejo, Juan Alejandro
700 1 _aSeki, Takuto
700 1 _aNonaka, Kanae
700 1 _aAsao, Rin
700 1 _aNagai-Hosoe, Yoshiko
700 1 _aAkiba-Takagi, Miyuki
700 1 _aHidaka, Teruo
700 1 _aTakagi, Masatoshi
700 1 _aKoyanagi, Akemi
700 1 _aMizutani, Shuki
700 1 _aYagita, Hideo
700 1 _aTomino, Yasuhiko
773 0 _tNature communications
_gvol. 5
_gp. 3296
856 4 0 _uhttps://doi.org/10.1038/ncomms4296
_zAvailable from publisher's website
999 _c23544337
_d23544337